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Abstract Regulator of telomere length 1 (RTEL1) is
a DNA helicase protein that has been demonstrated to
be required for the maintenance of telomere length and
genomic stability. It has also been found to be essential
for DNA homologous recombination during DNA
repairing. Human RTEL1 genomic locus (20q13.3) is
frequently amplified in multiple types of human
cancers, including hepatocellular carcinoma and gas-
trointestinal tract tumors, indicating that upregulated
RTEL1 activity could be important for tumorigenesis.
In this study, we have developed a conditional
transgenic mouse model that overexpress mouse Rtel1
in a Cre-excision manner. By crossing with a ubiqui-
tous Cre mouse line, we further demonstrated that
these established Rtel1 conditional transgenic mice
allow to efficiently and highly express a functional
Rtel1 that is able to rescue the embryonic defects of
Rtel1 null mouse allele. Furthermore, we demon-
strated that more than 70% transgenic mice that widely
overexpress Rtel1 developed liver tumors that reca-
pitulate many malignant features of human hepato-
cellular carcinoma (HCC). Our work not only
generated a valuable mouse model for determining
the role of RTEL1 in the development of cancers, but
also provided the first genetic evidence to support that
amplification of RTEL1, as observed in several types
of human cancers, is tumorigenic.
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Introduction
RTEL1 is a newly identified DNA helicase that has
been shown to be essential for the maintenance of
telomere length and genomic stability (Barber et al.
2008; Ding et al. 2004; Youds et al. 2010). It belongs
to the DEAH subfamily of the Superfamily 2 (SF2)
helicases and is further classified as a member of
DinG, Rad3-related DNA helicase with 50–30 direc-
tionality (Ding et al. 2004; Fairman-Williams et al.
2010). RTEL1 was identified in an effort to search for
the essential factors that govern the telomere length
diversity in mammalian species. In mice, Rtel1 gene is
located on distal chromosomal 2q region that has
previously been shown to be involved in the regulation
of mouse species-specific telomere length (Zhu et al.
1998). Mice with Rtel1 deficiency have global
telomere loss and multiple genomic instabilities, such
as chromosome fusions and breaks (Ding et al. 2004),
demonstrating that RTEL1 has an important role in the
regulation of telomere length and genomic stability.
More recently, RTEL1 was also found to be
required for DNA homologous recombination (HR)
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(Barber et al. 2008; Youds et al. 2010). HR is one of
the major pathways to maintain genomic stability and
is involved in the repair of complex DNA damage,
including DNA double-strand breaks (DSBs), inter-
strand crosslinks and DNA gaps. The function of HR
in the recovery of stalled and collapsed replication
forks is also critical to faithfully duplicate and
segregate the genome to daughter cells. Moreover,
HR has also been demonstrated to be essential for
accurate chromosome segregation during meiosis (see
a recent review by Heyer et al. 2010). One critical step
in HR is to form a D-loop structure by the invasion of
RAD51-single strand DNA filament into homologous
DNA template (Heyer et al. 2010; Holthausen et al.
2010; San Filippo et al. 2008). Within D-loops, the
invaded DNA strand serves as a primer for DNA
synthesis, and the synthesized DNA strand is subse-
quently displaced and annealed to the other processed
DNA end. This SDSA (synthesis-dependent strand
annealing) repair pathway leads to yield a non-
crossover repair product that can avoid crossover
and thus the possibility of deleterious genome rear-
rangements (Heyer et al. 2010). Therefore, SDSA is
considered as the predominant recombinational repair
pathway in somatic cells. RTEL1 was demonstrated to
promote SDSA by the disruption of D-loops in vitro
(Barber et al. 2008). Consistent with this biochemical
activity, depletion of RTEL1 in human cells was found
to have a fourfold increase in DSB-mediated intra-
chromosomal recombination (Barber et al. 2008), and
C. elegans with Rtel1 mutation showed significantly
increased crossover recombination during meiosis
(Barber et al. 2008; Youds et al. 2010). These results
strongly indicate that RTEL1 has an important func-
tion in anti-recombination. Since telomeres can form a
large duplex loop (T-loops) that largely resembles the
D-loops during HR (Griffith et al. 1999), this function
of RTEL1 could also be essential for the replication of
telomeres. In the absence of RTEL1, telomeric
T-loops could not be efficiently resolved, leading to
large telomeric deletions and other telomere dysfunc-
tion phenotypes as observed in Rtel1 null or Rtel1
knockdown cells (Ding et al. 2004; Sfeir et al. 2009).
Taken together, several recent studies have estab-
lished an essential role of RTEL1 DNA helicase in the
maintenance of telomere length and genomic stability.
Given that telomere dysfunction is dramatically
mutagenic and plays an important role in tumor
initiation and progression (Maser and DePinho 2002),
RTEL1 deficiency is expected to have a tumorigenic
function. However, as indicated by human genetic
data that RTEL1 genomic locus (20q13.3) is frequently
amplified in several human cancers (Bai et al. 2000;
Katoh et al. 2006; Muleris et al. 1995; Pitti et al. 1998;
Wong et al. 1999), upregulated RTEL1 activity could
also be important for tumorigensis. High RTEL1
activity may also induce genomic instability by
preventing HR (Uringa et al. 2011), leading to the
formation of tumor. As a first approach to determine
the role of increased RTEL1 activity in tumorigenesis,
in this study, we established a transgenic mouse model
that conditionally overexpress mouse Rtel1. We
further demonstrated that this established mouse
model can serve as a valuable genetic tool to assess
the tumorigenic function of upregulated RTEL1
activity in vivo. With this mouse model, we showed
for the first time that upregulated RTEL1, as observed
in human cancers, is tumorigenic and is able to initiate
the formation of hepatocellular carcinoma (HCC) in
mice.
Methods
Generation of Rtel1 conditional transgenic mice
The mouse Rtel1 cDNA with a 30 inserted V5 tag was
cloned to a conditional transgenic vector as described
previously (Ding et al. 2002). The transgenic vector
was verified by restriction enzymes and sequencing.
The transgenic vector was linearized with SacII and
then electroporated into R1 mouse embryonic stem
(ES) cells. The transfected ES cells were selected with
G418 (250 lg/ml). The G418-resistant ES clones were
screened by Southern blot analysis using a neo cDNA
probe. The genomic DNA was digested with multiple
restriction enzymes with unique digestion in the
transgenic vector (not in the probe region). Two
clones with overall, nonmosaic LacZ expression were
used to generate chimeric mice by ES cell()diploid
embryo aggregation. The transmitting chimeric males
were crossed with 129S1 inbred and ICR outbred
females to produce hemizygous transgenic offsprings,
which were then further bred with EIIa-Cre line (JAX
lab, Bar Harbor/Maine) to delete loxP flanked b-geo
cassette. The resulted mouse allele, termed pCX-
Rtel1-V5, was maintained in a 129S1/C57B6 back-
ground. All mouse experiments were performed in
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accordance with procedures approved by the Univer-
sity of Manitoba Animal Care and Use Committee.
A PCR based genotyping method was applied to
genotype pCX-Rtel1-V5 transgenic mice with the
primers: forward (50-TTCGGCTTCTGGCGTGTGA
CC-30) and reward (50-CTCGGAGATGTTGTTGCC
AGGC-30). One pair of primers: forward (50-AGCC
TCTGCTAACCATGTTCA-30) and reward (50-TGG
GATAGGTTACGTTGGTGT-30), were used to geno-
type Rtel1 conditional transgenic mice.
Immunohistochemistry
Mice were transcardially perfused with 4% parafor-
maldehyde in PBS buffer (pH 7.4). Tissues were
dissected, and then post-fixed in the same fixative
overnight. After a brief washing with PBS, the fixed
tissues were embedded in paraffin. 5 lm Paraffin-
embedded mouse tissue sections were pretreated with
Retrieval solution (Dako) for 20–30 min at 98.
Pretreated slides were blocked with either mouse
IgG blocking reagent (Vector Laboratory) or serum
free blocking reagent (Dako), and then incubated with
primary antibodies overnight at 4. Primary antibodies
used were rabbit anti-V5 (Abcam, dilution 1:1,000),
mouse anti-Ki67 (BD Pharmingen, dilution 1:100),
mouse anti-b-catenin (BD Pharmingen, dilution
1:200), and rabbit anti-AFP (Dako, dilution 1:500).
After washing with TBS with 0.1% Tween20 buffer,
sections were incubated with biotinylated anti-rabbit
or anti-mouse antibody for 60 min at room tempera-
ture. The sections were washed 3 times with TBS-
0.1% Tween20 buffer and incubated with avidin–
biotin-peroxidase complex (Vector Laboratory),
according to the manufacturer’s protocol. Color was
developed through the use of metal 3,30-diaminobenzi-
dine tetrachloride for 5 min at room temperature.
Western blot analysis
For western blots, mouse liver and lung tissues were
homogenized with ice-cold RIPA buffer. 30 lg lysate
was separated by 8% SDS-PAGE and transferred to
nitrocellulose membrane, which was blocked with 5%
de-fatted milk and incubated with mouse anti-V5
antibody (dilution 1:3,000, Invitrogen). Protein was
detected using the enhanced chemiluminescence sys-
tem (Amersham Life Science).
Results and discussion
To develop a mouse model that conditionally overex-
press mouse Rtel1, we applied a transgenic strategy as
described previously (Ding et al. 2002). Briefly, a
strong and ubiquitous promoter, pCAGGS (a chicken
b-actin promoter with the upstream CMV enhancer)
(Niwa et al. 1991), was used to drive the expression of
a loxP flanked b-geo cassette which is followed by
mouse Rtel1 cDNA. The Rtel1 expression can be
turned on only after Cre-mediated excision of loxP
flanked b-geo (Ding et al. 2002) (Fig. 1a). To facilitate
the detection of Rtel1 protein in transgenic mice, a V5
tag was inserted 30 downstream of the last coding
codon of Rtel1 cDNA. This addition will not affect the
cellular function of Rtel1 as demonstrated by the
previous studies (Barber et al. 2008; Ding et al. 2004).
The transgenic vector (Fig. 1a) was electroporated
into R1 ES cells. Clones with single copy insertion
were identified by Southern hybridization (Fig. 1b).
We applied the ES cell()diploid aggregation
assay to create chimeras from two independently
targeted ES clones. Both clones gave germline trans-
mission of transgenic allele. The transmitting chimeric
males were crossed with 129S1 inbred and ICR
outbred females to produce hemizygous transgenic
offspring that appeared normal and were fertile.
Without Cre recombinase-mediated excision, these
transgenic mice only expressed LacZ detected by
X-gal staining (data not shown). To determine Rtel1
expression upon Cre-mediated excision, we crossed
Rtel1 conditional transgenic mice with EIIa-Cre
transgenic mice (a ubiquitous Cre transgenic line).
The resulted mouse allele, termed pCX-Rtel1-V5, was
postnatal viable and fertile. We further applied
immunohistochemistry (IHC) to determine the expres-
sion of Rtel1-V5 protein in pCX-Rtel1-V5 adult mice
with anti-V5 antibody. As shown in Fig. 2, strong
nuclear-localized Rtel1-V5 protein was found to be
widely presented in most tissues, such as liver, lung,
heart, kidney, intestine and pancreas. We also applied
western blot to demonstrate that a 150 kd full length
Rtel1-V5 protein was expressed in pCX-Rtel1-V5
mouse tissues (Fig. 2g). This highly and widely
expression of Rtel1-V5 was consistently observed in
two independent conditional transgenic lines upon
EIIa-Cre-mediated excision, demonstrating that our
established Rtel1 conditional transgenic mice allow to
efficiently overexpress Rtel1 in vivo.
Transgenic Res (2012) 21:1109–1115 1111
123
To demonstrate that Rtel1-V5 protein expressed
from pCX-Rtel1-V5 transgenic mice is functional, we
bred pCX-Rtel1-V5 mice with Rtel1 null mouse allele.
We previously showed that Rtel1-/- mice were
embryonic lethal, and died between E9.5 and E10.5
with multiple developmental defects that are charac-
terized by neural tube defect (NTD), bulbous allantois,















Fig. 1 A transgenic approach for establishing Rtel1 conditional
transgenic mice. a Schematic representation of transgenic
vector. pCAGGS promoter (the fusion of a chicken b-actin
promoter with upstream CMV enhancer) is followed by a loxP
flanked b-geo with three SV40 polyadenylation signals (pA) and
a mouse Rtel1-V5 transgene. Prior to Cre excision, this
transgenic vector expresses only b-geo. The Rtel1-V5 expres-
sion is turned on after Cre-mediated excision. b Southern blot
analysis of transgene integration in R1 ES cells using a neo
cDNA probe. The genomic DNA was digested with restriction
enzymes with unique digestion in the transgenic vector (not in
the probe region), i.e.. ScaI and SphI. The potential ES clones
with a single copy and single site integration of the transgene
(labeled by asterisks) was further analyzed by another
restriction enzyme with unique digestion, StuI. All these
diagnostic digests were consistent with a single copy and single
site integration of the transgene
a b c
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Fig. 2 Characterization of Rtel1-V5 protein expression in
pCX-Rtel1-V5 mice. a–f IHC with anti-V5 antibody on mouse
tissues collected from 2 months old pCX-Rtel1-V5 mice. a liver;
b lung; c heart; d kidney; e intestine; f pancreas. g western blot
with anti-V5 antibody on mouse tissue lysates harvested from
pCX-Rtel1-V5 mice. 1 liver; 2 intestine; 3 liver from wild-type
control. Arrow indicates a major detected protein band with
150 Kd that matches with the predicted molecular weight of full
length Rtel1-V5 protein







Fig. 3 Development of liver tumors in pCX-Rtel1-V5 mice.
a Representative image of liver from a 12-month old pCX-Rtel1-
V5 mouse. Note the widespread tumor nodules throughout the
liver. b–f Histological characterization of liver tumors from
pCX-Rtel1-V5 mice reveals characteristics of hepatocellular
carcinoma. b shows a trabecular growth of multiple layers of
tumor cells. c shows increased mitotic figures (arrows indicate)
in tumor cells. d shows the multinucleated tumor cells (arrow).
e shows the cellular pleiomorphism with loss of cytoplasmic
staining. f shows the invasion of nodular tumor cells (arrows
indicate) to normal liver region (N). g IHC staining with anti-b-
catenin antibody reveals nuclear accumulation of b-catenin in
most tumor cells. h IHC staining with anti-AFP antibody. Some
regions of tumor cells showed strong positive for AFP
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(Ding et al. 2004; Wu et al. 2007). All these
phenotypes were not observed in Rtel-/-/pCX-Rtel1-
V5 E10.5 embryos. Rtel-/-/pCX-Rtel1-V5 mice were
postnatally viable, and showed similar behaviors as
other wild-type littermates. This clearly indicates that
expressed Rtel1-V5 protein in pCX-Rtel1-V5 trans-
genic mice has the same cellular function as native
Rtel1, which can completely rescue the developmental
defects of Rtel1 null mutants.
Lastly, we applied pCX-Rtel1-V5 transgenic mice
to determine whether upregulated Rtel1 activity could
induce the formation of tumors in vivo. For this
purpose, we monitored a cohort of 22 mice (12 pCX-
Rtel1-V5 mice and 10 wild type age matched litter-
mates) with a normal diet for a one-year period. At
12 months old, 8 out 12 pCX-Rtel1-V5 mice showed
weakness and decreased body weight as compared to
wild-type littermates. Post-mortem examination
revealed these pCX-Rtel1-V5 mice developed numer-
ous discrete nodules throughout the livers (Fig. 3a).
Upon histological analyses, these nodules were found
to display many pathological characteristics of HCC,
which include trabecular growth of multiple layers of
tumor cells (Fig. 3b), tumor cells with high mitotic
figures (Fig. 3c), cellular pleiomorphism with multi-
nucleated cells (Fig. 3d) or with loss of cytoplasmic
staining (Fig. 3e), and the invasion of nodular tumor
cells into the surrounding parenchyma (Fig. 3f).
Similar to some of human HCC, liver tumors from
pCX-Rtel1-V5 mice was also found to have increased
b-catenin activity (as reflected by the nuclear accu-
mulation of b-catenin in tumor cells) (Fig. 3g). Some
regions of liver tumors from pCX-Rtel1-V5 mice also
showed strong positive for a-fetoprotein (AFP)
(Fig. 3h), a diagnostic and prognostic marker in
human HCC. This liver tumor phenotype was consis-
tently present in two independent pCX-Rtel1-V5
transgenic lines. None of wild-type control mice
developed liver tumor at this developmental stage. All
these indicate that overexpression of Rtel1 in mouse
hepatocytes can induce the formation of liver tumors
that recapitulate many malignant features of HCC.
In summary, we have generated a conditional
mouse model that highly and efficiently expresses
Rtel1 upon Cre-mediated excision. We further con-
firmed that Rtel1-V5 protein expressed in this mouse
model is functional. More importantly, we demon-
strated that this established mouse model can serve as
a valuable genetic tool to assess the tumorigenic
function of upregulated RTEL1 activity in vivo. With
this model, we showed that increased expression of
Rtel1 in mouse hepatocytes induced the development
of HCC (Fig. 3). This finding is consistent with human
genetic data that amplification of RTEL1 genomic
locus is not only a common genetic alteration in HCC,
but also closely associated with its malignancy and
progression (Guan et al. 2000; Katoh et al. 2006;
Niketeghad et al. 2001; Taniguchi et al. 2010; Wong
et al. 1999). Therefore, our data indicate that upreg-
ulated RTEL1 activity could be a new genetic factor
involved in liver carcinogenesis. Future mechanistic
studies are required to provide insight into the nature
of the genomic instability in these tumors.
Given that RTEL1 gene is also frequently amplified
in other human cancers, such as gastrointestinal tract
tumors and breast cancers (Bai et al. 2000; Muleris
et al. 1995; Pitti et al. 1998), our established Rtel1
transgenic mouse model, which allows to overexpress
Rtel1 in a variety of cells or tissues, can also be applied
to determine the role of RTEL1 in the development of
these human cancers.
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